Clinical Trial Update: Sequential Changes of Serum KL-6 Predict Progression in Interstitial Lung Disease

View source ↗

Summary

This clinical trial update examines whether sequential changes in the serum biomarker KL-6 can predict progression in Desquamative interstitial pneumonia and ot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desquamative Interstitial Pneumonia
• Interstitial Lung Disease

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Interstitial Lung Disease, Desquamative | Status: UNKNOWN